RARE (RARE) Stock Price & Analysis
RARE (RARE) rose 3.03% to USD 15.3 as of September 8, 2026 at 05:02 UTC, according to Nexqual real-time market data.
RARE last closed at USD 15.3; the session ranged USD 15.24–16.08 on volume of 11,494,472 shares. Market capitalization is —, with a 52-week range of USD 13.81–39.89 (NMS). Source: Nexqual, September 8, 2026 at 05:02 UTC.
Key Statistics (as of September 8, 2026 at 05:02 UTC)
| Price | USD 15.3 |
|---|---|
| Change | ▲ 3.03% (up) |
| Previous Close | USD 15.3 |
| Open | USD 15.3 |
| Day Range | USD 15.24 – 16.08 |
| 52-Week Range | USD 13.81 – 39.89 |
| Volume | 11,494,472 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (RARE)
Nexqual's technical model rates RARE "SELL" based on 3 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 05:02 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 19.98 (oversold) |
| vs SMA50 | Below (USD 27.71) |
| MACD | -1.86 (negative) |
From RARE's Latest SEC 10-K Filing (filed 2026-02-18)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PTCT | PTC Therapeutics, Inc. | USD 69.3 | ▼ 3.47% |
| AGIO | Agios Pharmaceuticals, Inc. | USD 33.1 | ▼ 3.02% |
| RGNX | REGENXBIO Inc. | USD 8.94 | ▼ 6.88% |
| DNLI | Denali Therapeutics Inc. | USD 22.28 | ▼ 2.49% |
| QURE | uniQure N.V. | USD 44.5 | ▼ 3.74% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:02 UTC. This page is informational and not investment advice.